Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert R Butler

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 19, 2021
Sex-specific nicotine sensitization and imprinting of self-administration in rats inform GWAS findings on human addiction phenotypesAlena Kozlova, Robert R Butler, Siwei Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 18, 2025
Twenty years of therapeutic development in tauopathy mouse models: a scoping reviewVanessa F Langness, Danielle A Simmons, Tyne L M McHugh, et al.
Molecular Neuropsychiatry|May 14, 2020
The Genetic Relevance of Human Induced Pluripotent Stem Cell-Derived Microglia to Alzheimer's Disease and Major Neuropsychiatric DisordersRobert R Butler Iii, Alena Kozlova, Hanwen Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 7, 2026
Mapping cross-domain drivers of Alzheimer's disease risk through integrated network analysisGregory A Cary, Stephen Keegan, Jesse C Wiley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 10, 2026
Alzheimer's disease biological domain sub-stratification enhances the precision of functional analysesGregory A Cary, Sai Sruthi Amirtha Ganesh, Laura Heath, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2014
GATA-3 dose-dependent checkpoints in early T cell commitmentDeirdre D Scripture-Adams, Sagar S Damle, Long Li, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 31, 2021
Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75<sup>NTR</sup> Ligand LM11A-31Danielle A Simmons, Brian D Mills, Robert R Butler Iii, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Uncovering Heterogeneous Effects via Localized Feature SelectionXiaoxia Liu, Jiaqi Gu, Zhaomeng Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 23, 2024
A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse modelAmira Latif-Hernandez, Tao Yang, Robert R Butler, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 23, 2024
Genetic and multi-omic risk assessment of Alzheimer's disease implicates core associated biological domainsGregory A Cary, Jesse C Wiley, Jake Gockley, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 19, 2021
Sex-specific nicotine sensitization and imprinting of self-administration in rats inform GWAS findings on human addiction phenotypesAlena Kozlova, Robert R Butler, Siwei Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 18, 2025
Twenty years of therapeutic development in tauopathy mouse models: a scoping reviewVanessa F Langness, Danielle A Simmons, Tyne L M McHugh, et al.
Molecular Neuropsychiatry|May 14, 2020
The Genetic Relevance of Human Induced Pluripotent Stem Cell-Derived Microglia to Alzheimer's Disease and Major Neuropsychiatric DisordersRobert R Butler Iii, Alena Kozlova, Hanwen Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 7, 2026
Mapping cross-domain drivers of Alzheimer's disease risk through integrated network analysisGregory A Cary, Stephen Keegan, Jesse C Wiley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 10, 2026
Alzheimer's disease biological domain sub-stratification enhances the precision of functional analysesGregory A Cary, Sai Sruthi Amirtha Ganesh, Laura Heath, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2014
GATA-3 dose-dependent checkpoints in early T cell commitmentDeirdre D Scripture-Adams, Sagar S Damle, Long Li, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 31, 2021
Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75<sup>NTR</sup> Ligand LM11A-31Danielle A Simmons, Brian D Mills, Robert R Butler Iii, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Uncovering Heterogeneous Effects via Localized Feature SelectionXiaoxia Liu, Jiaqi Gu, Zhaomeng Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 23, 2024
A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse modelAmira Latif-Hernandez, Tao Yang, Robert R Butler, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 23, 2024
Genetic and multi-omic risk assessment of Alzheimer's disease implicates core associated biological domainsGregory A Cary, Jesse C Wiley, Jake Gockley, et al.
Pageof 3